← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 30, 2020Last known activity
Sep 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT06425133CollaboratorPhase 2Sep 30, 2024
- NCT05241405CollaboratorN/ASep 27, 2022
- NCT04570085CollaboratorPhase 3Nov 30, 2020
Details
- Last known activity
- Sep 30, 2024